it is always good to see progress in the rats,but when they need opportunity to move on to larger animals seams that they always loose their funding.
i reckon if we had the money that an NFL football player made we could take a trip overseas and get a try at it. ________________________________ From: kevin weilacher <hwyfli...@yahoo.com> To: Akua <a...@artfarm.com>; "tmic-list@eskimo.com" <tmic-list@eskimo.com> Sent: Tuesday, November 29, 2011 3:31 AM Subject: Re: [TMIC] Geron Halts Trial Because of No Money Geron pulling out of the stem cell research for MS and TM is old news..... There is new hope through Case Western Reserve University School Of Medicine (Cleveland Ohio)... They have some stem cell research currently going on to treat MS.... http://casemed.case.edu/dept/neurology/Research.html scroll down to where is says.... Translational Neurosciences Center Kevin NE Ohio (Canton) ________________________________ From: Akua <a...@artfarm.com> To: tmic-list@eskimo.com Sent: Monday, November 28, 2011 10:01 PM Subject: Re: [TMIC] Geron Halts Trial Because of No Money Re: [TMIC] Geron Halts Trial Because of No Money ROFLOL!!! if only i were the rat they say i am > >________________________________ > From: Akua <a...@artfarm.com> >To: tmic-list@eskimo.com >Sent: Monday, November 28, 2011 4:56 PM >Subject: [TMIC] Geron Halts Trial Because of No Money > >Another option bits the dust. > >http://topnews.us/content/244764-lack-funds-halting-embryonic-stem-cells-trail > >Now on 10/20 they announced progress in the trials > >This is the stuff that worked on rats >"GRNOPC1 contains hESC-derived oligodendrocyte progenitor cells that have demonstrated remyelinating, nerve growth stimulating and angiogenic properties leading to restoration of function in rodent models of acute spinal cord injury. Preclinical studies have shown that administration of GRNOPC1 significantly improved locomotor activity and kinematic scores of rodents with spinal cord injuries when injected seven days after the injury. Histological examination of the injured spinal cords treated with GRNOPC1 showed improved axon survival and extensive remyelination surrounding the rodent axons. For more information about GRNOPC1, visit www.geron.com/GRNOPC1Trial . For further information about the Phase 1 clinical trial, including location of clinical sites, visit www.clinicaltrials.gov/ct2/show/NCT01217008." > > >(sniff) >-- --
